World Child Cancer is connected to key partners, stakeholders, and decision-makers in the global childhood cancer community. Our international collaborations help improve access to treatment, strengthen healthcare systems, and advocate for policy change—ensuring that knowledge, resources, and best practices reach children everywhere.
Locally Led, Globally Connected
Key Global Collaborations
We work alongside leading global health initiatives to build sustainable solutions for childhood cancer care:
- World Health Organization (WHO) Global Initiative for Childhood Cancer (GICC)
We are an active stakeholder in the WHO Global Initiative for Childhood Cancer, which aims to increase survival rates to at least 60% by 2030 and reduce suffering for all children with cancer. We align our work with the CureAll framework, helping countries develop and integrate national childhood cancer strategies. - Global Platform for Access to Childhood Cancer Medicines
Access to life-saving medicines is a critical challenge in many countries where we work. We are collaborating with St. Jude and WHO to ensure that, by 2030, all our program countries benefit from this initiative to improve medicine availability and affordability. - Access to Oncology Medicines (ATOM) Coalition
We are exploring membership of the ATOM Coalition, led by the Union for International Cancer Control (UICC), which supports efforts to expand access to essential cancer medicines in low- and lower-middle-income countries. - The International Society of Pediatric Oncology (SIOP)
We are an active member of SIOP, supporting their mission to advance the study and care of children with cancer. SIOP is a truly global, multifaceted organization and is the only global multidisciplinary society entirely devoted to pediatric and adolescent cancer. - Access Cancer Treatment (ACT) for Children
ACT is a multi-stakeholder initiative uniting industry, the medical community, and patient advocates to safely introduce innovative child cancer therapies in LMICs. World Child Cancer US is proud to be a founding member.
Global Advocacy & Policy Influence
Our advocacy efforts ensure childhood cancer remains a priority at national and global levels. We focus on:
- Working with the WHO, international governmental and non-governmental institutions, and civil society to develop and deliver policies and programs that will improve childrens’ cancer treatment and care worldwide
- Improving access to effective treatment in low to middle-income countries.
- The inclusion of childrens’ cancer and non-communicable diseases in budgets, initiatives and priorities agreed by the international community
- Raising awareness globally through campaigns like International Childhood Cancer Day (ICCD) and Childhood Cancer Awareness Month (CCAM)
We engage with governments, health ministries, and multilateral organisations to influence policy and secure long-term investment in childhood cancer care.
Evidence-Based Research & Knowledge Sharing
Building a strong evidence base is key to improving survival rates and influencing policy. Our priorities include:
- Improving data collection and management to ensure hospitals and healthcare systems can implement improvements that have the greatest impact on survival and quality of life
- Collecting, analysing and publishing real-world evidence from our programs to improve awareness of what works - and what does not
- Developing adaptable models for early diagnosis, shared care networks, and family support
By generating and sharing evidence-based solutions, we support healthcare professionals, policymakers, and partners to implement the most effective strategies for childhood cancer care.
